There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|---|---|
| 1920.5 | 6 | 200 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
Annual Revenue,rose 22.61%, in the last year to ₹1,758.96 Cr. Its sector's average revenue growth for the last fiscal year was 16.16%.Annual Net Profit,rose 31.09% in the last year to ₹338.56 Cr. Its sector's average net profit growth for the last fiscal year was 91.08%.Price to Earning Ratio,is 52.11, lower than its sector PE ratio of 73.
Poly Medicure Ltd. (Polymed) is a leading Indian manufacturer and exporter of medical devices, established in 1995. The company offers a diverse portfolio of 200+ products spanning infusion therapy, anaesthesia, oncology, urology, and gastroenterology, and exports to more than 125 countries, supported by state-of-the-art manufacturing facilities that adhere to international quality standards and certifications. Polymed manufactures and supplies devices across infusion therapy, oncology, anaesthesia and respiratory care, urology, gastroenterology, vascular access, surgery and wound drainage, dialysis and renal care, diagnostics, transfusion systems, veterinary medical devices and others.
The company states it is the largest exporter of medical devices from India, with 70% of sales from exports to highly regulated developed markets like the EU, LATAM and South-East Asia; it is also among the top three IV cannula manufacturers globally and the first indigenous dialyzer manufacturer. Polymed’s footprint includes multiple units in Faridabad (Haryana), Haridwar (Uttarakhand) and Jaipur (SEZ, Rajasthan), along with overseas sites in Amaro, Italy; Laiyang–Qingdao, China; and Assuit, Egypt; the R&D Centre is located in Faridabad. As on the latest year, the company had 3 subsidiaries (and 3 step-subsidiaries) and employed 3,082 people.
These designations are as presented in the Annual Report’s statutory sections and financial statement sign-offs.
Polymed designs and manufactures medical devices across infusion therapy, oncology, anaesthesia and respiratory care, urology, gastroenterology, vascular access, surgery and wound drainage, dialysis and renal care, diagnostics, transfusion systems and veterinary medical devices. Its portfolio spans 200+ products for customers in India and abroad.
In India, the company operates multiple units in Faridabad (Haryana), Haridwar (Uttarakhand) and Jaipur SEZ (Rajasthan). Internationally, its footprint includes Amaro (Italy), Laiyang–Qingdao (China) and Assuit (Egypt), supported by an R&D Centre in Faridabad.
The company reports that 70% of its sales are from exports to highly regulated markets, including the EU, LATAM and South-East Asia. The remaining 30% are domestic sales in India.
